Liquiritigenin attenuates inflammatory periapical bone loss by stabilizing TRIM31 and restraining NLRP3 inflammasome and cGAS-STING inflammatory signaling

Experimental Cell Research · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles